Your session is about to expire
← Back to Search
Thyroid Hormone Therapy for Hypothyroidism
Study Summary
This trial is a study to compare the effect of different thyroid treatments on memory and other symptoms in patients with hypothyroidism.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- People with a mild form of underactive thyroid will not be included in the study. This is because it may be hard to see if the treatments work for them.I am not pregnant or at risk of becoming pregnant.I am 18-65 years old and have been taking levothyroxine for my thyroid condition for at least 6 months.
- Group 1: Levothyroxine Plus Liothyronine Group
- Group 2: Levothyroxine Group
- Group 3: Desiccated Thyroid Extract Group
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you elaborate on prior research conducted with the Levothyroxine Plus Liothyronine Group?
"Presently, 17 clinical trials are assessing the efficacy of Levothyroxine Plus Liothyronine Group with 4 studies reaching Phase 3. Of these 58 trial sites based in Jinan, Shandong province, some are evaluating this drug combination."
What conditions is the Levothyroxine Plus Liothyronine Group typically employed to treat?
"Levothyroxine Plus Liothyronine Group is an approved therapeutic intervention for a variety of thyroid-related diseases, including myxedema pre-coma and euthyroid goitre. Additionally, it can be prescribed as supplemental or replacement therapy."
Is enrolment for this experiment still open?
"Unfortunately, the data on clinicaltrials.gov suggests that this trial has ended its recruitment process as it was last updated on May 5th 2015. However, there are 30 other studies actively seeking new participants right now."
Are adults aged 30 or more suitable candidates for this experiment?
"This clinical trial is recruiting participants over the age of 18 and not yet 65 years old."
What criteria must individuals meet to qualify for participating in this clinical experiment?
"To be accepted into this clinical trial, candidates must have hypothyroidism and fit within the 18 to 65 years old age bracket. This medical study will recruit a total of 81 people."
What is the size of the sample group engaged in this clinical experiment?
"At this moment, enrolment for the trial has been suspended. Initially posted on May 1st 2015 and most recently updated on 5/5/2015, participants are no longer being accepted. Nevertheless, there remain 13 studies recruiting individuals with hypothyroidism and 17 trials actively searching for patients in Levothyroxine Plus Liothyronine Group."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger